U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Vulvar Squamous Cell Carcinoma

MedGen UID:
1740235
Concept ID:
C5420648
Neoplastic Process

Definition

The reemergence of vulvar squamous cell carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Vulvar Squamous Cell Carcinoma

Professional guidelines

PubMed

Nooij LS, Brand FA, Gaarenstroom KN, Creutzberg CL, de Hullu JA, van Poelgeest MI
Crit Rev Oncol Hematol 2016 Oct;106:1-13. Epub 2016 Jul 25 doi: 10.1016/j.critrevonc.2016.07.007. PMID: 27637349

Recent clinical studies

Etiology

van Doorn HC, Oonk MHM, Fons G, Gaarenstroom KN, de Hullu J, van Rosmalen J, van Beekhuizen HJ
BMC Cancer 2022 Apr 23;22(1):445. doi: 10.1186/s12885-022-09543-y. PMID: 35461213Free PMC Article
Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, Baratiny C, Maroun P, Morice P, Haie-Meder C, Chargari C
Brachytherapy 2017 May-Jun;16(3):518-525. Epub 2017 Mar 3 doi: 10.1016/j.brachy.2017.01.005. PMID: 28262516
Nooij LS, Brand FA, Gaarenstroom KN, Creutzberg CL, de Hullu JA, van Poelgeest MI
Crit Rev Oncol Hematol 2016 Oct;106:1-13. Epub 2016 Jul 25 doi: 10.1016/j.critrevonc.2016.07.007. PMID: 27637349
van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AG, Oonk MH, de Hullu JA
Gynecol Oncol 2016 Mar;140(3):415-9. Epub 2016 Jan 12 doi: 10.1016/j.ygyno.2016.01.013. PMID: 26797295
Han SN, Vergote I, Amant F
Int J Gynecol Cancer 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. PMID: 22552830

Diagnosis

Suero-Abreu GA, Lim P, Patel B, Thomas R
BMJ Case Rep 2022 Sep 2;15(9) doi: 10.1136/bcr-2021-245969. PMID: 37209004Free PMC Article
van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AG, Oonk MH, de Hullu JA
Gynecol Oncol 2016 Mar;140(3):415-9. Epub 2016 Jan 12 doi: 10.1016/j.ygyno.2016.01.013. PMID: 26797295
Han SN, Vergote I, Amant F
Int J Gynecol Cancer 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. PMID: 22552830

Therapy

Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, Baratiny C, Maroun P, Morice P, Haie-Meder C, Chargari C
Brachytherapy 2017 May-Jun;16(3):518-525. Epub 2017 Mar 3 doi: 10.1016/j.brachy.2017.01.005. PMID: 28262516
Han SN, Vergote I, Amant F
Int J Gynecol Cancer 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. PMID: 22552830

Prognosis

Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, Baratiny C, Maroun P, Morice P, Haie-Meder C, Chargari C
Brachytherapy 2017 May-Jun;16(3):518-525. Epub 2017 Mar 3 doi: 10.1016/j.brachy.2017.01.005. PMID: 28262516
Nooij LS, Brand FA, Gaarenstroom KN, Creutzberg CL, de Hullu JA, van Poelgeest MI
Crit Rev Oncol Hematol 2016 Oct;106:1-13. Epub 2016 Jul 25 doi: 10.1016/j.critrevonc.2016.07.007. PMID: 27637349
van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AG, Oonk MH, de Hullu JA
Gynecol Oncol 2016 Mar;140(3):415-9. Epub 2016 Jan 12 doi: 10.1016/j.ygyno.2016.01.013. PMID: 26797295
Han SN, Vergote I, Amant F
Int J Gynecol Cancer 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. PMID: 22552830

Clinical prediction guides

van Doorn HC, Oonk MHM, Fons G, Gaarenstroom KN, de Hullu J, van Rosmalen J, van Beekhuizen HJ
BMC Cancer 2022 Apr 23;22(1):445. doi: 10.1186/s12885-022-09543-y. PMID: 35461213Free PMC Article
Han SN, Vergote I, Amant F
Int J Gynecol Cancer 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. PMID: 22552830

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...